Leber Congenital Amaurosis
Ophthalmology·MeSH: Leber Congenital Amaurosis
Prevalence
5.0 / 100K
3 drugs in development·3 companies·4 clinical trials
Drug Pipeline by Phase
Preclinical(2)
Phase 1/Phase 2(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Leber Congenital Amaurosis?
BioSniper tracks 3 drugs in development for Leber Congenital Amaurosis across 3 companies.
How many clinical trials target Leber Congenital Amaurosis?
There are 4 clinical trials targeting Leber Congenital Amaurosis tracked by BioSniper.
What is the prevalence of Leber Congenital Amaurosis?
The estimated prevalence of Leber Congenital Amaurosis is approximately 5.0 per 100,000 population.
Deep-dive into Leber Congenital Amaurosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis